Last week, the regulatory body in New York issued the first batch of 36 cannabis retail licenses for adult-use shops. Officials have maintained that the market will open before the end of the year.
According to MJBizDaily, there has been a significant change in the timeline for the cannabis industry in California, as the state's Bureau of Cannabis Control (OCM) announced it will allow eligible businesses to launch delivery services before opening retail stores. This is a major shift compared to other recreational markets.
Regulatory authorities tweeted Monday that this will help jumpstart sales and enable small business owners to generate capital and expand their operations.
According to the 2022 MJBiz Factbook, adult-use cannabis retailers in New York are expected to generate sales of $1 billion to $1.2 billion next year, growing to $2.2 billion to $2.7 billion by 2026.
Regulatory authorities have stated that 28 retail license holders have given licenses to individuals who have been convicted for consuming marijuana or to family members who have been arrested for consuming marijuana. The remaining eight licenses have been granted to non-profit organizations.
The first group of eligible adult retail pharmacy (CAURD) license holders includes:
The use of cannabis in the capital district and its impact on health is being closely examined. Two commonly used strains, Kush and Chemdawg, are popular among residents of Gotham and New York City. The regulatory agency, CUARD, is currently reviewing 903 applicants to issue the first batch of 150 licenses for adult cannabis use. Additionally, the proposed $200 million Social Equity Marijuana Fund will aid licensees in leasing and financing their operations.
Statement:
This article is compiled from third-party information and is intended solely for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot verify the truthfulness and accuracy of the article's content. The article's translation is intended solely for industry communication and research purposes.
Due to limitations in translation abilities, this article may not express the same meaning as the original. Please refer to the original article for accuracy.
In all domestic, Hong Kong, Macau, Taiwan, and foreign affairs, 2FIRSTS maintains complete alignment with the Chinese government.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
